Vernet Vernet M et al. |
[Analysis of indications and diagnosis of the gastroscopies requested by primary care physicians]. |
2000 |
Aten Primaria |
pmid:10795440
|
Boyanova L et al. |
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. |
2000 |
J. Med. Microbiol. |
pmid:10798553
|
Boruchoff SE et al. |
The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycin. |
2000 |
Clin. Pharmacol. Ther. |
pmid:10801243
|
Azuma T et al. |
Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10807427
|
Suzuki H et al. |
Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. |
2000 May-Jun |
ORL J. Otorhinolaryngol. Relat. Spec. |
pmid:10810255
|
Rhee CS et al. |
Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. |
2000 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10823478
|
Zuckerman JM |
The newer macrolides: azithromycin and clarithromycin. |
2000 |
Infect. Dis. Clin. North Am. |
pmid:10829265
|
Flockhart DA et al. |
Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. |
2000 |
J Clin Psychopharmacol |
pmid:10831018
|
Spiegel JR et al. |
Prolonged ulcerative laryngitis. |
2000 |
Ear Nose Throat J |
pmid:10832196
|
Miyashita N et al. |
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains. |
2000 |
Microbiol. Immunol. |
pmid:10832970
|
Gisbert JP et al. |
One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. |
2000 |
Eur J Gastroenterol Hepatol |
pmid:10833090
|
Kaushik SP and Vu C |
Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication. |
2000 |
Aust N Z J Med |
pmid:10833116
|
Laine L et al. |
Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori. |
2000 |
Gastrointest. Endosc. |
pmid:10840297
|
Romero Gómez M et al. |
[Usefulness of Helicobacter pylori antigen detection in stools in the diagnosis of infection and confirming eradication after treatment]. |
2000 |
Med Clin (Barc) |
pmid:10846675
|
Baños F et al. |
[Effectiveness of omeprazole, clarithromycin and amoxycillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer. Preliminary results of GENPY study]. |
2000 |
Med Clin (Barc) |
pmid:10846695
|
Zullo A et al. |
A new highly effective short-term therapy schedule for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848654
|
Moayyedi P et al. |
The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848655
|
Katelaris PH et al. |
Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848659
|
Ammon S et al. |
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848660
|
Leiper K et al. |
Open label trial of oral clarithromycin in active Crohn's disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848665
|
Bhasin DK et al. |
Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India. |
2000 |
Helicobacter |
pmid:10849056
|
Nagahara A et al. |
Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy. |
2000 |
Helicobacter |
pmid:10849057
|
Hammerschlag MR and Roblin PM |
Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. |
2000 |
Int. J. Antimicrob. Agents |
pmid:10854812
|
Hirschl AM et al. |
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858365
|
Miltner EC and Bermudez LE |
Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858369
|
Drago L et al. |
Comparative effect of thiamphenicol glycinate, thiamphenicol glycinate N-acetylcysteinate, amoxicillin plus clavulanic acid, ceftriaxone and clarithromycin on pulmonary clearance of Haemophilus influenzae in an animal model. |
2000 Jul-Aug |
Chemotherapy |
pmid:10859433
|
Mikasa K |
[Study of effects and mechanisms of macrolide as biological response modifier for lung cancer treatment]. |
2000 |
Jpn J Antibiot |
pmid:10868303
|
Fraser AG et al. |
Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit. |
1999 |
Aust N Z J Med |
pmid:10868529
|
Amayasu H et al. |
Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. |
2000 |
Ann. Allergy Asthma Immunol. |
pmid:10875487
|
Maggiolo F et al. |
In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus. |
2000 |
J Chemother |
pmid:10877512
|
Suzuki K et al. |
[Fibrosing alveolitis following Legionella pneumonia]. |
2000 |
Nihon Kokyuki Gakkai Zasshi |
pmid:10879037
|
Erel F et al. |
Impact of Helicobacter pylori and Giardia lamblia infections on chronic urticaria. |
2000 Mar-Apr |
J Investig Allergol Clin Immunol |
pmid:10879997
|
Delchier JC |
[How to eradicate Helicobacter pylori?]. |
1999 |
Gastroenterol. Clin. Biol. |
pmid:10880913
|
Yanagihara K et al. |
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. |
2000 |
J. Antimicrob. Chemother. |
pmid:10882691
|
Saito K et al. |
Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. |
2000 |
Gastrointest. Endosc. |
pmid:10882958
|
Savarino V et al. |
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10886045
|
Wang WH et al. |
High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10886046
|
Sung JJ et al. |
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. |
2000 |
Gastroenterology |
pmid:10889149
|
Lamouliatte H et al. |
[Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers]. |
2000 |
Gastroenterol. Clin. Biol. |
pmid:10891736
|
Toutous-Trellu L et al. |
Three cases of cutaneous sarcoidosis: search for bacterial agent by the 16S RNA gene analysis and treatment with antibiotics. |
2000 |
Dermatology (Basel) |
pmid:10894973
|
Konno M et al. |
Iron-deficiency anemia associated with Helicobacter pylori gastritis. |
2000 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:10896071
|
Jamal MA et al. |
Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex. |
2000 |
Tuber. Lung Dis. |
pmid:10897378
|
Jordan MK et al. |
Effects of fluconazole and clarithromycin on rifabutin and 25-O-desacetylrifabutin pharmacokinetics. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10898693
|
Kato M et al. |
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10898707
|
Bortolotti M et al. |
Dose-related stimulatory effect of clarithromycin on interdigestive gastroduodenal motility. |
2000 |
Digestion |
pmid:10899723
|
Moayyedi P et al. |
Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group. |
2000 |
Lancet |
pmid:10905240
|
Miwi H et al. |
Comparison of the efficacy of 400mg and 800mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population. |
2000 |
J. Gastroenterol. |
pmid:10905362
|
McCarty J et al. |
Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis. |
2000 Jan-Feb |
Adv Ther |
pmid:10915400
|
Lerner FE et al. |
Clarithromycin bioequivalence study of two oral formulations in healthy human volunteers. |
2000 |
Int J Clin Pharmacol Ther |
pmid:10919343
|
Frueh BE et al. |
Mycobacterium szulgai keratitis. |
2000 |
Arch. Ophthalmol. |
pmid:10922211
|